Emulsifier Selection for Niacinamide Loading in High Water Phase Emulsions

In high-water-phase oil-in-water emulsions where the aqueous mass fraction is 75.0–90.0 wt% and niacinamide is dissolved in the water phase at 2.0–10.0 wt%, emulsifier selection is governed by continuous-phase osmotic stress, interfacial film viscoelasticity, and post-manufacturing droplet-size stability rather than by required HLB of the oil phase alone. The oil phase, typically a medium-chain triglyceride, isoamyl laurate, or caprylic/capric triglyceride at 5.0–15.0 wt%, presents a required HLB in the 10–12 range for conventional o/w emulsification, but that value is insufficient to predict stability when the continuous phase contains high levels of a freely water-soluble amide. Niacinamide competes with ethoxylated and polyglyceryl head groups for hydrogen-bonding water molecules, raises aqueous solubility parameter of the continuous phase, and can depress the phase-inversion temperature of nonionic ethoxylated emulsifiers during heating and cooling cycles. The consequence is that an emulsion which appears stable immediately after rotor-stator mixing may undergo rapid coalescence or phase inversion during accelerated storage at 45°C under ISO/TR 18811:2018 stability screening. Selection work therefore begins with pre-screening of emulsifier solubility and cloud behavior in the aqueous phase at pH 5.5–6.5, because niacinamide hydrolysis to nicotinic acid occurs at pH below 4.0 and above 7.0 at elevated temperature and is monitored by HPLC with UV detection at 260 nm according to USP <621>. Batch preparation on a laboratory scale uses a rotor-stator homogenizer such as an IKA T25 digital Ultra-Turrax at 8,000–10,000 rpm for 3–5 minutes to disperse the oil phase into the aqueous phase, followed by cooling from 70–75°C to 25°C at 0.5°C/min with anchor stirring. Droplet-size distribution is measured by laser diffraction using a Malvern Mastersizer 3000 after 24 h and after each thermal cycle, with D50 and span treated as primary acceptance parameters; a D50 below 5 µm and span below 2.0 are typically required to prevent creaming and Ostwald ripening in systems with such low oil-phase volume fractions.

Why Does Niacinamide Addition Shift the Phase-Inversion Temperature of Ethoxylated Nonionics?

Phase-inversion temperature screening is more predictive than HLB calculation for nonionic ethoxylated emulsifiers in high-water-phase systems because the ethoxylate hydration shell responds directly to changes in aqueous-phase polarity and solute content. The measurement is conducted by heating a stirred formulation from 25°C to 85°C at 0.5°C/min while recording electrical conductivity with a Mettler Toledo SevenCompact conductivity meter fitted with an InLab 731 electrode. The temperature at which conductivity shows an abrupt change corresponds to phase inversion from oil-in-water to water-in-oil, and the cooling inversion temperature is recorded as the formulation is cooled back to 20°C. In a high-water-phase vehicle containing 5.0 wt% niacinamide, an ethoxylated system such as ceteareth-20 combined with cetearyl alcohol may show a phase-inversion temperature below 55°C; industrial practice requires the phase-inversion temperature to be at least 20°C above the maximum anticipated storage temperature to avoid inversion during filling or warehousing. The depression arises because niacinamide interacts with the polyoxyethylene chain through hydrogen bonding, reducing the number of water molecules available for surfactant hydration and lowering the temperature at which the emulsifier becomes lipophilic. Published data for specific niacinamide-ethoxylate binary pairs is limited because commercial emulsifier composition is not fully disclosed, so formulators rely on the phase-inversion temperature scan as an empirical screening tool. When the cooling phase-inversion temperature falls below 50°C, the formulation is reformulated using either a non-ethoxylated emulsifier or a mixed system in which a high-HLB ethoxylate is partially replaced with a polyglyceryl ester or glucoside. The conductivity-temperature curve also identifies whether phase inversion is reversible and whether the emulsion remains o/w during the entire cooling stage; irreversible inversion or conductivity hysteresis greater than 5°C between heating and cooling cycles indicates that the interfacial film does not re-form quickly enough to preserve the fine droplet distribution generated during homogenization.

A 500 kg vacuum processing kettle equipped with a rotor-stator homogenizer and side-scraper agitator highlights why laboratory emulsifier selection does not transfer directly to production. In the laboratory, a 200 g batch may be homogenized at 10,000 rpm with a tip speed near 12 m/s, while the production kettle homogenizer typically operates at 2,900–3,600 rpm with tip speeds of 10–20 m/s but with significantly longer recirculation times. The vacuum level in the production vessel is held at −0.08 MPa to reduce air entrainment, and the molten oil phase is added to the aqueous phase at 70–75°C under side-scraper agitation of 15–25 rpm. Emulsifier systems that rely on laminar liquid-crystal formation—such as cetearyl alcohol with glyceryl stearate citrate or sodium stearoyl lactylate—are sensitive to cooling rate, and a cooling rate faster than 0.7°C/min can prevent the α-gel network from ordering at the interface. Production batches are characterized by polarized light microscopy and oscillatory rheology; a TA Instruments DHR-2 fitted with a 40 mm parallel plate is used to measure storage modulus at 1 Hz across a strain sweep from 0.1% to 100%. The crossover strain is recorded as the limit of linear viscoelastic structure, and values below 1% indicate brittle interfacial and bulk gel structure. Batch-to-batch variation in high-water-phase niacinamide systems often appears as a shift in yield stress rather than in visual separation; yield stress measured by oscillatory shear is compared against the target range of 2–12 Pa sufficient to suspend oil droplets of 5–15 µm diameter. When the same formula is transferred from a IKA T25 batch to a fryma-type vacuum kettle, the D50 may increase from 3 µm to 8 µm if emulsifier concentration is not adjusted upward by 0.2–0.5 wt% to compensate for lower shear residence time.

Electrolyte Tolerance, Lamellar Gel Networks, and Polymeric Steric Stabilizers in 75–85 wt% Aqueous Systems

High-water-phase emulsions containing niacinamide are not true electrolyte systems, but the high solute load created by niacinamide, humectants, chelating agents, and botanical extracts generates an osmotic environment that can deswell charged emulsifier layers. Anionic emulsifiers such as potassium cetyl phosphate and sodium stearoyl lactylate are effective at forming small droplets under high shear, but their interfacial films are sensitive to calcium and magnesium ions introduced through tap water or botanical extracts; formulation water is therefore specified at ≤ 10 µS/cm conductivity after reverse osmosis and deionization, and chelation is achieved with tetrasodium glutamate diacetate at 0.1–0.2 wt%. Nonionic lamellar gel networks formed from cetearyl alcohol, glyceryl stearate, and polyglyceryl-3 methylglucose distearate are generally more tolerant of water-phase solutes, but their formation requires a precise mass ratio of high-melting fatty alcohol to emulsifier. At niacinamide loadings above 5.0 wt%, the lamellar gel network may show reduced birefringence under polarized light microscopy if insufficient free water remains for emulsifier head-group hydration; this is accompanied by an increase in D50 from 3–5 µm to 10–20 µm after 4 weeks at 40°C. The formulation response is to add glycerin at 5.0–15.0 wt% to the aqueous phase while maintaining water content above 75.0 wt%, or to replace part of the fatty alcohol with a polymeric steric stabilizer such as polyacrylate crosspolymer-6 or acrylates/C10-30 alkyl acrylate crosspolymer at 0.1–0.5 wt%. These polymers increase continuous-phase viscosity and reduce the collision frequency of oil droplets, but they are rheology modifiers rather than primary emulsifiers and cannot replace the interfacial layer. The primary emulsifier package in such systems typically remains a combination of polyglyceryl-3 dicitrate/stearate and cetearyl glucoside at 2.0–4.0 wt%, with the polymer added after emulsification to avoid excessive shear degradation. Oscillatory temperature sweeps from 20°C to 80°C at 1°C/min are used to verify that storage modulus does not collapse below 10 Pa at 45°C, and the data are recorded under ASTM D4065-20 dynamic mechanical analysis practice.

Cold-process high-water gel-creams containing 0.2–0.5 wt% acrylates/C10-30 alkyl acrylate crosspolymer, 0.1–0.3 wt% xanthan gum, and a dispersed oil phase of 5.0–10.0 wt% are frequently designated as high-aqueous-phase systems but cannot be manufactured through a molten-oil heating step. The emulsifier must therefore be a cold-processable liquid or pre-dispersed lamellar concentrate, such as polyglyceryl-4 laurate/sebacate combined with sodium stearoyl lactylate, or a liquid crystal emulsion concentrate supplied at 2.0–5.0 wt%. Cold-process manufacturing uses a vacuum disperser at 2,000–4,000 rpm rather than a high-shear homogenizer, because the acrylate polymer network is sensitive to permanent shear thinning at tip speeds above 8 m/s. Neutralization with sodium hydroxide to final pH 5.8–6.2 is performed after emulsification, because niacinamide-loaded gels acidified below 5.5 by acidic botanical additives show increased hydrolysis to nicotinic acid. The yield stress of the finished gel is measured by vane rheometry at 20°C using a Brookfield RVT with a T-C spindle at 5 rpm, with a target of 3–10 Pa; lower values allow droplet creaming within 2 weeks at 40°C, while higher values produce an undesirable stringy texture during tube filling. In-process viscosity is monitored every 15 minutes after neutralization because viscosity drift of ± 1,000 mPa·s occurs as the polymer hydrates. The manufacturing phase is completed by passing the batch through a 200 µm mesh filter before filling; filtration at smaller pore sizes can shear-degrade the xanthan gum network and produce a measurable loss of yield stress.

When High-Pressure Homogenization Reduces Droplet Size but Destroys Polymeric Yield Stress

For low-viscosity sprayable emulsions with water content above 85.0 wt%, a two-stage high-pressure homogenizer operating at 500/50 bar can reduce D50 from 8 µm to 2 µm after a single pass, but the same process can also degrade high molecular weight polyacrylate rheology modifiers if they are present during the pass. The compromise is to emulsify without the polymer, then add a pre-dispersed carbomer slurry under low-shear mixing at 50–100 rpm. When the polymer is exposed to multiple passes at 500 bar, viscosity measured by ASTM D2196-20 Method A declines by more than 30% and does not recover after 24 h of quiescent storage, indicating irreversible chain scission. For high-water-phase niacinamide systems containing 0.2 wt% polymer, the high-pressure homogenization step is therefore confined to the oil and low-molecular-weight emulsifier mixture, with the polymer phase blended in afterward. The droplet-size benefit of high-pressure homogenization is only retained if the primary emulsifier surface coverage is sufficient at the smaller droplet diameter; if the emulsifier package is not adjusted upward by 0.3–1.0 wt%, the newly created interfacial area leads to rapid coalescence and visible oiling within 72 h at 40°C. Laser diffraction data from a Mastersizer 3000 after high-pressure homogenization show a span widening from 1.5 to 3.2 within 48 h when coalescence is active, even though the D50 remains nominally unchanged. The use of high-pressure homogenization is therefore reserved for formulations where the selected emulsifier system has a sufficiently fast adsorption rate, such as polyglyceryl-3 caprate or polyglyceryl-6 laurate at 2.0–4.0 wt%, and where the final rheology is provided by a post-added polymer.

Does Niacinamide Loading Change Preservative Partitioning and Challenge Test Outcomes?

High-water-phase emulsions present a larger aqueous compartment for preservative partitioning, and the presence of 2.0–10.0 wt% niacinamide can shift the apparent solubility of preservatives such as phenoxyethanol, benzyl alcohol, and organic acids by altering the aqueous phase polarity. Preservative efficacy is evaluated by ISO 11930:2019 challenge testing with Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Candida albicans, and Aspergillus brasiliensis; the acceptance criteria require at least a 3 log reduction for bacteria by 7 days with no subsequent increase by 28 days, and no increase for fungi from the 14-day count through 28 days. Because the aqueous phase is continuous and above 75.0 wt%, preservative solubility in the aqueous phase is high, but binding to nonionic emulsifier micelles or to polyacrylate polymer networks can reduce the free preservative fraction. In practice, a preservative system containing phenoxyethanol at 0.5–1.0 wt% and ethylhexylglycerin at 0.05–0.15 wt% is challenged after aging the formulation for 7 days at 25°C so that any binding equilibrium is established before inoculation. Water activity is measured by ISO 18787:2017 using an Aqualab 4TE at 25°C, with values for high-water systems typically above 0.92; this does not by itself prevent microbial growth, so the challenge test remains the controlling acceptance method. Niacinamide is a water-soluble vitamin that can serve as a nutrient source for some microorganisms, so preservative demand in high-water formulations containing 5.0–10.0 wt% niacinamide is not reduced relative to a water-only vehicle. The manufacturing environment is maintained under ISO 22716:2007 GMP, and bulk product is held no longer than 48 h before filling to limit microbial proliferation before preservative equilibrium is achieved.

The compliance and characterization matrix in Table 1 consolidates the methods used to evaluate emulsifier selection and final emulsion quality for high-water-phase niacinamide vehicles. These methods are used during development, scale-up, and release testing, with the specified acceptance windows derived from internal formulation experience and public standard requirements.